Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Athena Technology Acquisition (ATEK) Competitors

Athena Technology Acquisition logo

ATEK vs. CRTX, OMCL, HSTM, MDRX, RRAC, IPXX, RENE, TPBA, ENPC, and AXAC

Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Rigel Resource Acquisition (RRAC), Inflection Point Acquisition Corp. II (IPXX), Cartesian Growth Co. II (RENE), TPB Acquisition Co. I (TPBA), Executive Network Partnering (ENPC), and AXIOS Sustainable Growth Acquisition (AXAC).

Athena Technology Acquisition vs. Its Competitors

Cortexyme (NASDAQ:CRTX) and Athena Technology Acquisition (NYSE:ATEK) are both small-cap health care technology companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

In the previous week, Cortexyme and Cortexyme both had 1 articles in the media. Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cortexyme
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Athena Technology Acquisition
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cortexyme has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Athena Technology Acquisition has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500.

63.2% of Cortexyme shares are owned by institutional investors. Comparatively, 17.3% of Athena Technology Acquisition shares are owned by institutional investors. 27.9% of Cortexyme shares are owned by company insiders. Comparatively, 88.4% of Athena Technology Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.

Company Net Margins Return on Equity Return on Assets
CortexymeN/A -70.96% -63.53%
Athena Technology Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CortexymeN/AN/A-$89.94M-$2.97-0.60
Athena Technology AcquisitionN/AN/AN/AN/AN/A

Summary

Athena Technology Acquisition beats Cortexyme on 4 of the 6 factors compared between the two stocks.

Get Athena Technology Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEK vs. The Competition

MetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE Exchange
Market Cap$101.50M$182.05M$2.01B$20.79B
Dividend YieldN/A3.12%13.72%3.71%
P/E RatioN/A2.2612.2727.89
Price / SalesN/A553.702,543,432.3142.50
Price / CashN/A89.8861.9422.63
Price / BookN/A8.873.244.57
Net IncomeN/A-$7.63M-$475.68M$988.81M

Athena Technology Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEK
Athena Technology Acquisition
N/A$10.00
flat
N/AN/A$101.50MN/A0.002,021
CRTX
Cortexyme
N/A$1.71
+6.2%
N/A+147.2%$51.56MN/A-0.5855
OMCL
Omnicell
3.4881 of 5 stars
$29.77
-0.6%
$44.83
+50.6%
+7.2%$1.40B$1.11B64.723,670Analyst Upgrade
HSTM
HealthStream
4.312 of 5 stars
$27.21
-0.7%
$31.50
+15.8%
-6.3%$836.39M$291.65M43.191,093Positive News
MDRX
Veradigm
2.8872 of 5 stars
$4.60
-2.1%
$13.00
+182.6%
-48.7%$498.02M$1.53B0.008,000News Coverage
RRAC
Rigel Resource Acquisition
N/A$11.50
flat
N/AN/A$368.81MN/A0.002,021
IPXX
Inflection Point Acquisition Corp. II
N/A$9.79
-0.5%
N/A+3.7%$305.94MN/A0.00N/ANews Coverage
Gap Down
High Trading Volume
RENE
Cartesian Growth Co. II
N/A$11.75
flat
N/A+3.8%$254.05MN/A0.002
TPBA
TPB Acquisition Co. I
N/A$2.09
-2.3%
N/A-59.3%$247.98MN/A0.002
ENPC
Executive Network Partnering
N/A$5.88
-3.4%
N/A-9.8%$247.04MN/A0.001High Trading Volume
AXAC
AXIOS Sustainable Growth Acquisition
N/A$10.43
flat
N/AN/A$228.66MN/A0.00N/AHigh Trading Volume

Related Companies and Tools


This page (NYSE:ATEK) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners